SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Mudcat who wrote (17629)3/18/1998 3:59:00 PM
From: Hippieslayer  Respond to of 32384
 
It could be possible that LGND will not apply for the NDA this quarter and instead used the Deal as a "replacement". We will know is this is the case soon.



To: Mudcat who wrote (17629)3/18/1998 4:15:00 PM
From: bluejeans  Respond to of 32384
 
Hello Mudcat,

You may have a valid point about waiting (if you are Ligand).<G> But since this is a deal between 2 parties, both must be agreeable.
I am happy to see the deal done. I am also happy that Ligand will bear the fruit of any additional research in this area, without needing to spend valuable monies. I am just happy to have made it through another day;)

Bob (a happy camper)

PS. Hope that the filing does create a move upwards in the stock and that it is a move that stays and not just a temporary jump.<G> But if there is no buying pressure after the filing, it will not go up. So, I hope everyone justs waits until the filing to buy Ligand.;)



To: Mudcat who wrote (17629)3/18/1998 4:42:00 PM
From: tuck  Respond to of 32384
 
Mudcat,

From my perspective, Ligand's stock price lost ground in the past year in part because some bears believed the leptin deal, so long delayed, might never come. Thus news the deal is signed after all should provide solid support and should be released as soon as possible. With it as a base, the news of NDA's should spark less "sell on the news" downside.

Tuck



To: Mudcat who wrote (17629)3/18/1998 4:56:00 PM
From: Flagrante Delictu  Read Replies (1) | Respond to of 32384
 
Mudcat, Why didn't LGND wait? It's hard to know what price a stock will sell for at a specific date in the future.
The rest of the thread seems to feel that an NDA filing might have a positive impact on the stock, but you have pointed out how LGND management doesn't think the stock is worth what it's selling for.
In that case, wouldn't you try to jam it down the throats of the drug companies that are so anxiously accumulating it? LGND is getting a 20% premium now & received $6.67 per share for the right to jam 150,000 warrants to SBH exercisable at $20 per share in 5 yrs., with certain rights to force the sm _cks to exercise after only 3 yrs.
LGND would then have received a total of $26.67 for those exercised shares.
In the remote event {according to your analysis that mgt. thinks the stock is too high now } that the drug companies might even know what they are doing; and, therefore that your analysis is flawed, then, mgt. still has the chance to buy the stock back from them after the drug cos. "start selling" { which you mentioned}, or even worse, panic and regurgitate their stock into the bottom of a waterfall decline of '87-like proportions. That could be a heck of a trading profit for any mgt. that knows what it's stock is worth.
How about "them" apples? Bernie